Matches in SemOpenAlex for { <https://semopenalex.org/work/W2036006558> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W2036006558 endingPage "783" @default.
- W2036006558 startingPage "779" @default.
- W2036006558 abstract "Background Miller et al demonstrated that the combination of bevacizumab and paclitaxel has significant activity in metastatic breast cancer (MBC). Because albumin-bound paclitaxel has been shown to have less toxicity, a better tumor delivery, and possibly better response for MBC, we combined it with bevacizumab to treat women with MBC. Patients and Methods This is a retrospective analysis. Billing records from March 2005 through December 2006 were reviewed to identify all patients treated with a combination of albumin-bound paclitaxel/bevacizumab. A total of 40 women were identified. They received a minimum of 2 courses. Patients with measurable disease were monitored for response using Response Evaluation Criteria in Solid Tumors. Women with bone-only disease were monitored with positron emission tomography (PET)/computed tomography/magnetic resonance imaging and tumor markers. All response data were confirmed by independent review. Results Of 33 women with measurable disease, 16 had objective responses to the albumin-bound paclitaxel/bevacizumab regimen (3 complete responses and 13 partial responses) for an overall response rate (ORR) of 48.5%. Median time to progression for responders was 128 days. Another 5 women had stable disease (SD) with a median duration of 135 days. Of 7 patients with bone-only disease, 2 had almost complete resolution of PET activity and 4 had SD (median, 148 days). Toxicity was acceptable with fatigue, neuropathy, pain, and hypertension being the most common complaints. Conclusion In our limited series of women with advanced, heavily pretreated MBC treated with albumin-bound paclitaxel/bevacizumab, we saw a 48.5% ORR. The regimen was well tolerated. Randomized studies are needed to confirm efficacy and safety of this combination in treating breast cancer." @default.
- W2036006558 created "2016-06-24" @default.
- W2036006558 creator A5005473474 @default.
- W2036006558 creator A5057707389 @default.
- W2036006558 creator A5058090610 @default.
- W2036006558 creator A5077902295 @default.
- W2036006558 date "2007-10-01" @default.
- W2036006558 modified "2023-09-26" @default.
- W2036006558 title "Bevacizumab and Albumin-Bound Paclitaxel Treatment in Metastatic Breast Cancer" @default.
- W2036006558 cites W1603578607 @default.
- W2036006558 cites W1998188518 @default.
- W2036006558 cites W2052118631 @default.
- W2036006558 cites W2068014745 @default.
- W2036006558 cites W2078775260 @default.
- W2036006558 cites W2128941584 @default.
- W2036006558 cites W2145835533 @default.
- W2036006558 cites W2153017356 @default.
- W2036006558 cites W2154632843 @default.
- W2036006558 cites W2164934025 @default.
- W2036006558 cites W2170016968 @default.
- W2036006558 cites W2211922157 @default.
- W2036006558 doi "https://doi.org/10.3816/cbc.2007.n.039" @default.
- W2036006558 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18021479" @default.
- W2036006558 hasPublicationYear "2007" @default.
- W2036006558 type Work @default.
- W2036006558 sameAs 2036006558 @default.
- W2036006558 citedByCount "29" @default.
- W2036006558 countsByYear W20360065582013 @default.
- W2036006558 countsByYear W20360065582014 @default.
- W2036006558 countsByYear W20360065582015 @default.
- W2036006558 countsByYear W20360065582016 @default.
- W2036006558 countsByYear W20360065582018 @default.
- W2036006558 countsByYear W20360065582019 @default.
- W2036006558 countsByYear W20360065582023 @default.
- W2036006558 crossrefType "journal-article" @default.
- W2036006558 hasAuthorship W2036006558A5005473474 @default.
- W2036006558 hasAuthorship W2036006558A5057707389 @default.
- W2036006558 hasAuthorship W2036006558A5058090610 @default.
- W2036006558 hasAuthorship W2036006558A5077902295 @default.
- W2036006558 hasConcept C121608353 @default.
- W2036006558 hasConcept C126322002 @default.
- W2036006558 hasConcept C126838900 @default.
- W2036006558 hasConcept C141071460 @default.
- W2036006558 hasConcept C143409427 @default.
- W2036006558 hasConcept C143998085 @default.
- W2036006558 hasConcept C2775930923 @default.
- W2036006558 hasConcept C2776694085 @default.
- W2036006558 hasConcept C2777292972 @default.
- W2036006558 hasConcept C2777802072 @default.
- W2036006558 hasConcept C2778822529 @default.
- W2036006558 hasConcept C2779984678 @default.
- W2036006558 hasConcept C2781413609 @default.
- W2036006558 hasConcept C530470458 @default.
- W2036006558 hasConcept C71924100 @default.
- W2036006558 hasConcept C90924648 @default.
- W2036006558 hasConceptScore W2036006558C121608353 @default.
- W2036006558 hasConceptScore W2036006558C126322002 @default.
- W2036006558 hasConceptScore W2036006558C126838900 @default.
- W2036006558 hasConceptScore W2036006558C141071460 @default.
- W2036006558 hasConceptScore W2036006558C143409427 @default.
- W2036006558 hasConceptScore W2036006558C143998085 @default.
- W2036006558 hasConceptScore W2036006558C2775930923 @default.
- W2036006558 hasConceptScore W2036006558C2776694085 @default.
- W2036006558 hasConceptScore W2036006558C2777292972 @default.
- W2036006558 hasConceptScore W2036006558C2777802072 @default.
- W2036006558 hasConceptScore W2036006558C2778822529 @default.
- W2036006558 hasConceptScore W2036006558C2779984678 @default.
- W2036006558 hasConceptScore W2036006558C2781413609 @default.
- W2036006558 hasConceptScore W2036006558C530470458 @default.
- W2036006558 hasConceptScore W2036006558C71924100 @default.
- W2036006558 hasConceptScore W2036006558C90924648 @default.
- W2036006558 hasIssue "10" @default.
- W2036006558 hasLocation W20360065581 @default.
- W2036006558 hasLocation W20360065582 @default.
- W2036006558 hasOpenAccess W2036006558 @default.
- W2036006558 hasPrimaryLocation W20360065581 @default.
- W2036006558 hasRelatedWork W2033027303 @default.
- W2036006558 hasRelatedWork W2035195370 @default.
- W2036006558 hasRelatedWork W2036006558 @default.
- W2036006558 hasRelatedWork W2077649377 @default.
- W2036006558 hasRelatedWork W2080607747 @default.
- W2036006558 hasRelatedWork W2091442233 @default.
- W2036006558 hasRelatedWork W2147013188 @default.
- W2036006558 hasRelatedWork W2163003060 @default.
- W2036006558 hasRelatedWork W2388730008 @default.
- W2036006558 hasRelatedWork W2592838365 @default.
- W2036006558 hasVolume "7" @default.
- W2036006558 isParatext "false" @default.
- W2036006558 isRetracted "false" @default.
- W2036006558 magId "2036006558" @default.
- W2036006558 workType "article" @default.